lancet semaglutide tirzepatide for maintenance of bodyweight reduction in people with obesity in the USA (SURMOUNT-MAINTAIN): a multicentre, double-blind, randomised, placebo-controlled trial Tirzepatide vs. Semaglutide: Which is – Lilly's oral GLP-1, orforglipron, delivered

If you received your semaglutide from a compounding pharmacy and are unsure of the concentration, 2.5 mg/mL is the most likely option, though you should always verify with the label

The effects of GLP-1 receptor agonists on inhibition of food intake and body weight loss are currently of considerable interest (118)

Storgaard H, Cold F, Gluud LL, Vilsbll T, Knop FK

Imadojemu et al

*Based on manufacturer trials of the 7.2 mg dose in adults with obesity alongside diet and exercise (vs ~4% with diet and exercise alone)

The benefits of GIPR engagement seem to be primarily mediated through improved adipose tissue health